Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C. +25 more·1995·Nature
DOI 10.1038/375754a0

Cited by (222)

Items 101–200 of 222

  1. 2D versus 3D Human Induced Pluripotent Stem Cell-Derived Cultures for Neurodegenerative Disease Modelling
    Centeno, Eduarda G Z, Cimarosti, Helena, Bithell, Angela · 2018 · Molecular Neurodegeneration
  2. Alzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
    Szaruga, Maria, Munteanu, Bogdan, Lismont, Sam, Veugelen, Sarah, Horré, Katrien, Mercken, Marc, Saido, Takaomi C., Ryan, Natalie S., De Vos, Tatjana, Savvides, Savvas N. et al. · 2017 · Cell
  3. Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests
    Bates, K A, Verdile, G, Li, Q-X, Ames, D, Hudson, P, Masters, C L, Martins, R N · 2009 · Molecular Psychiatry
  4. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease
    Hirsch-Reinshagen, Veronica, Maia, Luis F., Burgess, Braydon L., Blain, Jean-Francois, Naus, Kathryn E., McIsaac, Sean A., Parkinson, Pamela F., Chan, Jennifer Y., Tansley, Gavin H., Hayden, Michael R. et al. · 2005 · Journal of Biological Chemistry
  5. Untangling Genetic Risk for Alzheimer’s Disease
    Pimenova, Anna A., Raj, Towfique, Goate, Alison M. · 2018 · Biological Psychiatry
  6. The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
    Drachman, David A. · 2014 · Alzheimer's & Dementia
  7. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer’s disease
    Ling, Yan, Morgan, Kevin, Kalsheker, Noor · 2003 · The International Journal of Biochemistry & Cell Biology
  8. Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
    Wojsiat, Joanna, Zoltowska, Katarzyna Marta, Laskowska-Kaszub, Katarzyna, Wojda, Urszula · 2018 · Oxidative Medicine and Cellular Longevity
  9. Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
    Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles · 2011 · Journal of Controlled Release
  10. Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
    Migliore, Lucia, Coppedè, Fabio · 2022 · Nature Reviews Neurology
  11. Mouse Models of Alzheimer’s Disease
    Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
  12. Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
    Govindpani, Karan, Calvo-Flores Guzmán, Beatriz, Vinnakota, Chitra, Waldvogel, Henry, Faull, Richard, Kwakowsky, Andrea · 2017 · International Journal of Molecular Sciences
  13. The Alzheimer's disease mitochondrial cascade hypothesis: an update
    Swerdlow, Russell H., Khan, Shaharyar M. · 2009 · Experimental Neurology
  14. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease
    Kirouac, Lisa, Rajic, Alexander J., Cribbs, David H., Padmanabhan, Jaya · 2017 · eneuro
  15. Structural basis of γ-secretase inhibition and modulation by small molecule drugs
    Yang, Guanghui, Zhou, Rui, Guo, Xuefei, Yan, Chuangye, Lei, Jianlin, Shi, Yigong · 2021 · Cell
  16. Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred
    Pastor, Pau, Roe, Catherine M., Villegas, Andrés, Bedoya, Gabriel, Chakraverty, Sumi, García, Gloria, Tirado, Victoria, Norton, Joanne, Ríos, Silvia, Martínez, Maribel et al. · 2003 · Annals of Neurology
  17. TUDCA, a Bile Acid, Attenuates Amyloid Precursor Protein Processing and Amyloid-β Deposition in APP/PS1 Mice
    Nunes, Ana F., Amaral, Joana D., Lo, Adrian C., Fonseca, Maria B., Viana, Ricardo J. S., Callaerts-Vegh, Zsuzsanna, D’Hooge, Rudi, Rodrigues, Cecília M. P. · 2012 · Molecular Neurobiology
  18. Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis
    Guo, Qing, Robinson, Nic, Mattson, Mark P. · 1998 · Journal of Biological Chemistry
  19. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes
    Wong, Tak Pan, Debeir, Thomas, Duff, Karen, Cuello, A. Claudio · 1999 · The Journal of Neuroscience
  20. Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ<sub>42(43)</sub>
    Mann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M. et al. · 1996 · Annals of Neurology
  21. Amyloid Angiopathy and Variability in Amyloid β Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer’s Disease
    Mann, David M.A., Pickering-Brown, Stuart M., Takeuchi, Ayano, Iwatsubo, Takeshi · 2001 · The American Journal of Pathology
  22. TREM2 in CNS homeostasis and neurodegenerative disease
    Painter, Meghan M., Atagi, Yuka, Liu, Chia-Chen, Rademakers, Rosa, Xu, Huaxi, Fryer, John D., Bu, Guojun · 2015 · Molecular Neurodegeneration
  23. Correlating familial Alzheimer’s disease gene mutations with clinical phenotype
    Ryan, Natalie S, Rossor, Martin N · 2010 · Biomarkers in Medicine
  24. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia
    Ferrer, Isidro · 2012 · Progress in Neurobiology
  25. Lipopolysaccharide-Induced Memory Impairment in Rats: a Model of Alzheimer’s Disease
    ZAKARIA, R., WAN YAACOB, W. M. H., OTHMAN, Z., LONG, I., AHMAD, A. H., AL-RAHBI, B. · 2017 · Physiological Research
  26. Molecular Genetics of Late‐Onset Alzheimer's Disease
    Kamboh, M. Ilyas · 2004 · Annals of Human Genetics
  27. A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases
    Paulsen, Jane S., Nance, Martha, Kim, Ji-In, Carlozzi, Noelle E., Panegyres, Peter K., Erwin, Cheryl, Goh, Anita, McCusker, Elizabeth, Williams, Janet K. · 2013 · Progress in Neurobiology
  28. Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain
    Lah, James J., Heilman, Craig J., Nash, Norman R., Rees, Howard D., Yi, Hong, Counts, Scott E., Levey, Allan I. · 1997 · The Journal of Neuroscience
  29. The presenilin genes: a new gene family involved in Alzheimer disease pathology
    Cruts, Marc, Hendriks, Lydia, Van Broeckhoven, Christine · 1996 · Human Molecular Genetics
  30. The P2X7 Receptor: Central Hub of Brain Diseases
    Andrejew, Roberta, Oliveira-Giacomelli, Ágatha, Ribeiro, Deidiane Elisa, Glaser, Talita, Arnaud-Sampaio, Vanessa Fernandes, Lameu, Claudiana, Ulrich, Henning · 2020 · Frontiers in Molecular Neuroscience
  31. Two rare <i>AKAP9</i> variants are associated with Alzheimer's disease in African Americans
    Logue, Mark W., Schu, Matthew, Vardarajan, Badri N., Farrell, John, Bennett, David A., Buxbaum, Joseph D., Byrd, Goldie S., Ertekin‐Taner, Nilufer, Evans, Denis, Foroud, Tatiana et al. · 2014 · Alzheimer's &amp; Dementia
  32. Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice
    Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G. et al. · 1997 · Human Molecular Genetics
  33. Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology
    Fukami, Shinjiro, Watanabe, Kaori, Iwata, Nobuhisa, Haraoka, Jo, Lu, Bao, Gerard, Norma P., Gerard, Craig, Fraser, Paul, Westaway, David, George-Hyslop, Peter St. et al. · 2002 · Neuroscience Research
  34. Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
    Park, Jun Sung, Lee, Junehawk, Jung, Eun Sun, Kim, Myeong-Heui, Kim, Il Bin, Son, Hyeonju, Kim, Sangwoo, Kim, Sanghyeon, Park, Young Mok, Mook-Jung, Inhee et al. · 2019 · Nature Communications
  35. Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity
    Puig, Kendra L., Floden, Angela M., Adhikari, Ramchandra, Golovko, Mikhail Y., Combs, Colin K. · 2012 · PLoS ONE
  36. The discovery of Alzheimer‐causing mutations in the <scp>APP</scp> gene and the formulation of the “amyloid cascade hypothesis”
    Hardy, John · 2017 · The FEBS Journal
  37. Protein Folding in the Endoplasmic Reticulum and the Unfolded Protein Response
    Zhang, K., Kaufman, R.J. · 2005 · Handbook of Experimental Pharmacology
  38. Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's Disease
    Funderburk, Sarah F., Marcellino, Bridget K., Yue, Zhenyu · 2010 · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
  39. Overlap between neurodegenerative disorders
    Armstrong, Richard A., Lantos, Peter L., Cairns, Nigel J. · 2005 · Neuropathology
  40. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
    Cristóvão, Joana S., Santos, Renata, Gomes, Cláudio M. · 2016 · Oxidative Medicine and Cellular Longevity
  41. Making the final cut: Pathogenic amyloid-β peptide generation by γ-secretase
    Steiner, Harald, Fukumori, Akio, Tagami, Shinji, Okochi, Masayasu · 2018 · Cell Stress
  42. Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
    2008 · Handbook of Clinical Neurology
  43. Reduced Reelin Expression Accelerates Amyloid-  Plaque Formation and Tau Pathology in Transgenic Alzheimer's Disease Mice
    Kocherhans, S., Madhusudan, A., Doehner, J., Breu, K. S., Nitsch, R. M., Fritschy, J.-M., Knuesel, I. · 2010 · Journal of Neuroscience
  44. Parenchymal and vascular Aβ‐deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
    Thal, Dietmar Rudolf, Griffin, W. Sue T., Braak, Heiko · 2008 · Journal of Cellular and Molecular Medicine
  45. Animal models of Alzheimer disease: historical pitfalls and a path forward
    Cavanaugh, Sarah E. · 2014 · ALTEX
  46. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
    Sleegers, Kristel, Lambert, Jean-Charles, Bertram, Lars, Cruts, Marc, Amouyel, Philippe, Van Broeckhoven, Christine · 2010 · Trends in Genetics
  47. The Future of Precision Medicine in the Cure of Alzheimer’s Disease
    Arafah, Azher, Khatoon, Saima, Rasool, Iyman, Khan, Andleeb, Rather, Mashoque Ahmad, Abujabal, Khaled Abdullah, Faqih, Yazid Abdullilah Hassan, Rashid, Hina, Rashid, Shahzada Mudasir, Bilal Ahmad, Sheikh et al. · 2023 · Biomedicines
  48. Examination of the current top candidate genes for AD in a genome-wide association study
    Feulner, T M, Laws, S M, Friedrich, P, Wagenpfeil, S, Wurst, S H R, Riehle, C, Kuhn, K A, Krawczak, M, Schreiber, S, Nikolaus, S et al. · 2010 · Molecular Psychiatry
  49. Genetic architecture of Alzheimer's disease
    Neuner, Sarah M., TCW, Julia, Goate, Alison M. · 2020 · Neurobiology of Disease
  50. Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice
    Wirths, Oliver, Multhaup, Gerd, Czech, Christian, Feldmann, Nicole, Blanchard, Véronique, Tremp, Günter, Beyreuther, Konrad, Pradier, Laurent, Bayer, Thomas A. · 2002 · Brain Pathology
  51. Mitochondria in Alzheimer's disease
    Swerdlow, Russell H., Kish, Stephen J. · 2002 · International review of neurobiology
  52. Familial Alzheimer’s disease mutations in PSEN1 lead to premature human stem cell neurogenesis
    Arber, Charles, Lovejoy, Christopher, Harris, Lachlan, Willumsen, Nanet, Alatza, Argyro, Casey, Jackie M., Lines, Georgie, Kerins, Caoimhe, Mueller, Anika K., Zetterberg, Henrik et al. · 2021 · Cell Reports
  53. γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43
    Okochi, Masayasu, Tagami, Shinji, Yanagida, Kanta, Takami, Mako, Kodama, Takashi S., Mori, Kohji, Nakayama, Taisuke, Ihara, Yasuo, Takeda, Masatoshi · 2013 · Cell Reports
  54. Circulating Biomarkers of Cognitive Decline and Dementia
    Solfrizzi, Vincenzo, D'Introno, Alessia, Colacicco, Anna Maria, Capurso, Cristiano, Todarello, Orlando, Pellicani, Vincenza, Capurso, Sabrina A, Pietrarossa, Giuseppe, Santamato, Vito, Capurso, Antonio et al. · 2006 · Clinica Chimica Acta
  55. Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
    Gurney, Mark E., D'Amato, Emily C., Burgin, Alex B. · 2015 · Neurotherapeutics
  56. A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2
    Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., Sisodia, S. S. · 2012 · Journal of Neuroscience
  57. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
    Sala Frigerio, Carlo, De Strooper, Bart · 2016 · Annual Review of Neuroscience
  58. Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
    Grueninger, Fiona, Bohrmann, Bernd, Czech, Christian, Ballard, Theresa Maria, Frey, Johann R., Weidensteiner, Claudia, von Kienlin, Markus, Ozmen, Laurence · 2010 · Neurobiology of Disease
  59. Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease
    Basun, Hans, Bogdanovic, Nenad, Ingelsson, Martin, Almkvist, Ove, Näslund, Jan, Axelman, Karin, Bird, Thomas D., Nochlin, David, Schellenberg, Gerard D., Wahlund, Lars-Olof et al. · 2008 · Archives of Neurology
  60. Amyloid‐β protein (Aβ) Glu11 is the major β‐secretase site of β‐site amyloid‐β precursor protein‐cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis
    Deng, Yu, Wang, Zhe, Wang, Ruitao, Zhang, Xiaozhu, Zhang, Shuting, Wu, Yili, Staufenbiel, Matthias, Cai, Fang, Song, Weihong · 2013 · European Journal of Neuroscience
  61. APP Function and Lipids: A Bidirectional Link
    Grimm, Marcus O. W., Mett, Janine, Grimm, Heike S., Hartmann, Tobias · 2017 · Frontiers in Molecular Neuroscience
  62. Increased Aβ42(43) from cell lines expressing presenilin 1 mutations
    Mehta, Nitin D., Refolo, Lawrence M., Eckman, Chris, Sanders, Sunny, Yager, Debra, Perez‐Tur, Jordi, Younkin, Steve, Duff, Karen, Hardy, John, Hutton, Mike · 1998 · Annals of Neurology
  63. Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein
    Citron, Martin, Eckman, Christopher B., Diehl, Thekla S., Corcoran, Chris, Ostaszewski, Beth L., Xia, Weiming, Levesque, Georges, St. George Hyslop, Peter, Younkin, Steven G., Selkoe, Dennis J. · 1998 · Neurobiology of Disease
  64. Wnt/&amp;#946;-Catenin Signaling in Alzheimer’s Disease
    Ferrari, Giancarlo, Avila, Miguel, Medina, Matias, Perez-Palma, Eduardo, Bustos, Bernabe, Alarcon, Marcelo · 2014 · CNS &amp; Neurological Disorders - Drug Targets
  65. Presenilins and Alzheimer's disease
    Kim, Tae-Wan, Tanzi, Rudolph E · 1997 · Current Opinion in Neurobiology
  66. Multiple cellular and molecular mechanisms Are involved in human Aβ clearance by transplanted adult astrocytes
    Pihlaja, Rea, Koistinaho, Jari, Kauppinen, Riitta, Sandholm, Jouko, Tanila, Heikki, Koistinaho, Milla · 2011 · Glia
  67. Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
    Dominantly Inherited Alzheimer Network, Ringman, John M., Goate, Alison, Masters, Colin L., Cairns, Nigel J., Danek, Adrian, Graff-Radford, Neill, Ghetti, Bernardino, Morris, John C. · 2014 · Current Neurology and Neuroscience Reports
  68. Biomarkers in Neurodegenerative Diseases
    Jeromin, Andreas, Bowser, Robert · 2017 · Advances in Neurobiology
  69. The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice
    Hu, L, Wong, T.P, Côté, S.L, Bell, K.F.S, Cuello, A.C · 2003 · Neuroscience
  70. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
    Knuesel, Irene · 2010 · Progress in Neurobiology
  71. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
    Pritchard, Susanne M., Dolan, Philip J., Vitkus, Alisa, Johnson, Gail V.W. · 2011 · Journal of Cellular and Molecular Medicine
  72. Sorting Nexin 27 Regulates Aβ Production through Modulating γ-Secretase Activity
    Wang, Xin, Huang, Timothy, Zhao, Yingjun, Zheng, Qiuyang, Thompson, Robert C., Bu, Guojun, Zhang, Yun-wu, Hong, Wanjin, Xu, Huaxi · 2014 · Cell Reports
  73. Shifting paradigms: The central role of microglia in Alzheimer’s disease
    Schwabe, Tina, Srinivasan, Karpagam, Rhinn, Herve · 2020 · Neurobiology of Disease
  74. The Relationship between Amyloid and Tau
    Hardy, John · 2003 · Journal of Molecular Neuroscience
  75. APOE and other loci affect age‐at‐onset in Alzheimer's disease families with PS2 mutation
    Wijsman, Ellen M., Daw, E. Warwick, Yu, Xuesong, Steinbart, Ellen J., Nochlin, David, Bird, Thomas D., Schellenberg, Gerard D. · 2005 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  76. Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
    Szyf, Moshe · 2015 · European Neuropsychopharmacology
  77. Early-Onset Alzheimer Disease in Families With Late-Onset Alzheimer Disease: A Potential Important Subtype of Familial Alzheimer Disease
    Brickell, Kiri L., Steinbart, Ellen J., Rumbaugh, Malia, Payami, Haydeh, Schellenberg, Gerard D., Van Deerlin, Vivianna, Yuan, Wuxing, Bird, Thomas D. · 2006 · Archives of Neurology
  78. Function and Dysfunction of the Presenilins
    Sisodia, Sangram S., Kim, Seong H., Thinakaran, Gopal · 1999 · The American Journal of Human Genetics
  79. Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N<sup>141</sup>I)
    Nochlin, David, Bird, Thomas D., Nemens, Ellen J., Ball, Melvyn J., Sumi, S. Mark · 1998 · Annals of Neurology
  80. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer’s disease patients
    Sala Frigerio, Carlo, Lau, Pierre, Troakes, Claire, Deramecourt, Vincent, Gele, Patrick, Van Loo, Peter, Voet, Thierry, De Strooper, Bart · 2015 · Alzheimer's &amp; Dementia
  81. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies
    Farfel, Jose M., Yu, Lei, Buchman, Aron S., Schneider, Julie A., De Jager, Philip L., Bennett, David A. · 2016 · Neurology
  82. Dedifferentiation and neuronal repression define familial Alzheimer’s disease
    Caldwell, Andrew B., Liu, Qing, Schroth, Gary P., Galasko, Douglas R., Yuan, Shauna H., Wagner, Steven L., Subramaniam, Shankar · 2020 · Science Advances
  83. Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease
    Welsh‐Bohmer, Kathleen A., Gearing, Marla, Saunders, Ann M., Roses, Allen D., Mirra, Suzanne · 1997 · Annals of Neurology
  84. APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
    Jordà‐Siquier, Tomàs, Petrel, Melina, Kouskoff, Vladimir, Smailovic, Una, Cordelières, Fabrice, Frykman, Susanne, Müller, Ulrike, Mulle, Christophe, Barthet, Gaël · 2022 · Alzheimer's &amp; Dementia
  85. A novel mechanism for the regulation of amyloid precursor protein metabolism
    Chen, Qi, Kimura, Hideo, Schubert, David · 2002 · The Journal of Cell Biology
  86. <i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease
    Quiroz, Yakeel T., Aguillon, David, Aguirre-Acevedo, Daniel C., Vasquez, Daniel, Zuluaga, Yesica, Baena, Ana Y., Madrigal, Lucia, Hincapié, Liliana, Sanchez, Justin S., Langella, Stephanie et al. · 2024 · New England Journal of Medicine
  87. A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease
    Mukhopadhyay, Sanchari, Banerjee, Debanjan · 2021 · Journal of Alzheimer s Disease
  88. Blood cell-produced amyloid-β induces cerebral Alzheimer-type pathologies and behavioral deficits
    Sun, Hao-Lun, Chen, Si-Han, Yu, Zhong-Yuan, Cheng, Yuan, Tian, Ding-Yuan, Fan, Dong-Yu, He, Chen-Yang, Wang, Jun, Sun, Pu-Yang, Chen, Yang et al. · 2021 · Molecular Psychiatry
  89. Central and peripheral circadian clocks and their role in Alzheimer's disease
    Chauhan, Ruchi, Chen, Ko-Fan, Kent, Brianne A., Crowther, Damian C. · 2017 · Disease Models &amp; Mechanisms
  90. Turning the tide on Alzheimer’s disease: modulation of γ-secretase
    Luo, Joanna E., Li, Yue-Ming · 2022 · Cell &amp; Bioscience
  91. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21
    Hales, Chadwick M, Seyfried, Nicholas T, Dammer, Eric B, Duong, Duc, Yi, Hong, Gearing, Marla, Troncoso, Juan C, Mufson, Elliott J, Thambisetty, Madhav, Levey, Allan I et al. · 2014 · Molecular Neurodegeneration
  92. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
    Su, Yi, Blazey, Tyler M., Owen, Christopher J., Christensen, Jon J., Friedrichsen, Karl, Joseph-Mathurin, Nelly, Wang, Qing, Hornbeck, Russ C., Ances, Beau M., Snyder, Abraham Z. et al. · 2016 · PLOS ONE
  93. Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
    Deng, Zhiqiang, Dong, Yu, Zhou, Xiaoting, Lu, Jia-Hong, Yue, Zhenyu · 2022 · Acta Pharmaceutica Sinica B
  94. Ocular manifestations of Alzheimer's disease in animal models
    Parnell, Miles, Guo, Li, Abdi, Mohamed, Cordeiro, M. Francesca · 2012 · International Journal of Alzheimer s Disease
  95. Protective Effect of D609 Against Amyloid-Beta1-42-Induced Oxidative Modification of Neuronal Proteins: Redox Proteomics Study
    Sultana, Rukhsana, Newman, Shelley F., Abdul, Hafiz Mohmmad, Cai, Jian, Pierce, William M., Klein, Jon B., Merchant, Michael, Butterfield, D. Allan · 2006 · Journal of Neuroscience Research
  96. Microtubule transport defects in neurological and ciliary disease
    Gerdes, J. M., Katsanis, N. · 2005 · Cellular and Molecular Life Sciences
  97. Is sleep disruption a risk factor for Alzheimer's disease?
    Macedo, Arthur Cassa, Balouch, Sara, Tabet, Naji · 2017 · Journal of Alzheimer’s Disease
  98. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease
    Beck, Tim N., Nicolas, Emmanuelle, Kopp, Meghan C., Golemis, Erica A. · 2014 · Oncoscience
  99. Clinical, biological, and imaging features of monogenic Alzheimer’s disease
    Pilotto, Andrea, Padovani, Alessandro, Borroni, Barbara · 2013 · BioMed Research International
  100. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
    Pádua, Mafalda Soares, Guil-Guerrero, José L., Prates, José A. M., Lopes, Paula Alexandra · 2024 · International Journal of Molecular Sciences